On regular monitoring during treatment for primary hyperparathyroidism, which nutrient is most likely to be monitored and potentially supplemented?

• A. Calcium
• B. Magnesium
• C. Vitamin D
• D. Iron

Answer: (C)

The key idea is calcium homeostasis and bone health in primary hyperparathyroidism. When the parathyroid glands are overactive, PTH raises blood calcium and stimulates bone breakdown. Vitamin D is essential for calcium absorption from the gut and for bone mineralization, so its status directly affects both calcium balance and bone health in this condition. If vitamin D levels are low, PTH can stay inappropriately high to try to maintain calcium, which can worsen bone loss. Therefore, clinicians routinely check vitamin D status and, if deficient, supplement vitamin D to improve calcium absorption, support bone density, and help modulate PTH activity, all while monitoring calcium levels to avoid pushing them higher. Calcium itself is already elevated in this condition, so routine supplementation is not preferred and can risk worsening hypercalcemia, while iron isn’t linked to the management of PHPT. Magnesium and other minerals are monitored if indicated, but vitamin D is the nutrient most likely to be monitored and supplemented in this context.